{"id":470598,"date":"2021-04-05T07:08:23","date_gmt":"2021-04-05T11:08:23","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=470598"},"modified":"2021-04-05T07:08:23","modified_gmt":"2021-04-05T11:08:23","slug":"clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/","title":{"rendered":"Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ALPHARETTA, Ga., April  05, 2021  (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will present at two upcoming virtual conferences in April 2021:<\/p>\n<p align=\"justify\">\n        <strong>Needham Virtual Healthcare Conference <\/strong><br \/>\n        <br \/>Monday, April 12, 2021 at 12:45 p.m. ET<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">The live and archived Needham Virtual Healthcare Conference presentation webcast may be accessed on the Clearside website under the Investors section: <a href=\"https:\/\/ir.clearsidebio.com\/events-and-presentations\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Events and Presentations<\/a>.<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>Wet AMD &amp; DME Drug Development Summit <\/strong><br \/>\n        <br \/>Wednesday, April 14, 2021<br \/>Event details are available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CUYPpqDXwD_gsJHZ3H4rhEXhGc8J5ahcyydEHCbg-UfVtWzaFPfE0o0KkfjLVlxs91GAcp2MmgtqtaHBRPeQF0O-jgJq9OHz46ncXC_GciY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">conference website<\/a>.<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">10:45 a.m. ET &#8211; Panel Discussion: Ending the Burden of Monthly Treatments \u2013 Mechanisms to Increasing the Durability &amp; Accessibility of Wet AMD &amp; DME Therapeutics<\/li>\n<li style=\"text-align:justify\">1:40 p.m. ET &#8211; Suprachoroidal Drug Delivery &amp; CLS-AX: A Potential Solution for Treatment Burden<\/li>\n<li style=\"text-align:justify\">2:55 p.m. ET &#8211; Chair Led Q&amp;A: Making Strides Forward in Drug Delivery &amp; Dosing<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>About Clearside Biomedical<\/strong>\n      <\/p>\n<p align=\"justify\">Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Clearside\u2019s proprietary SCS Microinjector<sup>\u00ae<\/sup> targeting the suprachoroidal space (SCS<sup>\u00ae<\/sup>) offers unique access to the macula, retina and choroid where sight-threatening disease often occurs. The Company\u2019s SCS injection platform is an inherently flexible, in-office, non-surgical procedure, intended to provide targeted delivery to the site of disease and to work with both established and new formulations of medications. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6El3xqOmaYGvTwMkEjq4-PY7U61PxGgMKTz_36rYfJYAnMy-uj-ebGkUkifv0yK1NLsQFEQrxG1eB7LDnfJQRyybxAA68vFDwBx2OYBlk70=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.clearsidebio.com<\/a>.<\/p>\n<p>\n        <strong>Investor and Media Contacts:<\/strong><br \/>\n        \n      <\/p>\n<p>Jenny Kobin <br \/>Remy Bernarda <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_nhsBlNo0T_Pc0EhOVMuaeyOsuNQ98kdjwAl95IrI4S5O7eRkIPRWbnYrPElRft3PxtWbOlcP39UC-EKOTn2z3-osEy9s58xkMIw-mmgwNk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ir@clearsidebio.com<\/a><br \/>(678) 430-8206<\/p>\n<p>Source: Clearside Biomedical, Inc.<\/p>\n<p>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTE1NyM0MTA0OTc3IzIwMTExNjI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/6e12eab2-3b58-41e2-be07-6228206f7906\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ALPHARETTA, Ga., April 05, 2021 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will present at two upcoming virtual conferences in April 2021: Needham Virtual Healthcare Conference Monday, April 12, 2021 at 12:45 p.m. ET The live and archived Needham Virtual Healthcare Conference presentation webcast may be accessed on the Clearside website under the Investors section: Events and Presentations. Wet AMD &amp; DME Drug Development Summit Wednesday, April 14, 2021Event details are available on the conference website. 10:45 a.m. ET &#8211; Panel Discussion: Ending &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-470598","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ALPHARETTA, Ga., April 05, 2021 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will present at two upcoming virtual conferences in April 2021: Needham Virtual Healthcare Conference Monday, April 12, 2021 at 12:45 p.m. ET The live and archived Needham Virtual Healthcare Conference presentation webcast may be accessed on the Clearside website under the Investors section: Events and Presentations. Wet AMD &amp; DME Drug Development Summit Wednesday, April 14, 2021Event details are available on the conference website. 10:45 a.m. ET &#8211; Panel Discussion: Ending &hellip; Continue reading &quot;Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-05T11:08:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTE1NyM0MTA0OTc3IzIwMTExNjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit\",\"datePublished\":\"2021-04-05T11:08:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\\\/\"},\"wordCount\":297,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTE1NyM0MTA0OTc3IzIwMTExNjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\\\/\",\"name\":\"Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTE1NyM0MTA0OTc3IzIwMTExNjI=\",\"datePublished\":\"2021-04-05T11:08:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTE1NyM0MTA0OTc3IzIwMTExNjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTE1NyM0MTA0OTc3IzIwMTExNjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/","og_locale":"en_US","og_type":"article","og_title":"Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit - Market Newsdesk","og_description":"ALPHARETTA, Ga., April 05, 2021 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will present at two upcoming virtual conferences in April 2021: Needham Virtual Healthcare Conference Monday, April 12, 2021 at 12:45 p.m. ET The live and archived Needham Virtual Healthcare Conference presentation webcast may be accessed on the Clearside website under the Investors section: Events and Presentations. Wet AMD &amp; DME Drug Development Summit Wednesday, April 14, 2021Event details are available on the conference website. 10:45 a.m. ET &#8211; Panel Discussion: Ending &hellip; Continue reading \"Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-05T11:08:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTE1NyM0MTA0OTc3IzIwMTExNjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit","datePublished":"2021-04-05T11:08:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/"},"wordCount":297,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTE1NyM0MTA0OTc3IzIwMTExNjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/","name":"Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTE1NyM0MTA0OTc3IzIwMTExNjI=","datePublished":"2021-04-05T11:08:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTE1NyM0MTA0OTc3IzIwMTExNjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTE1NyM0MTA0OTc3IzIwMTExNjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-present-at-the-needham-virtual-healthcare-conference-and-wet-amd-dme-drug-development-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD &amp; DME Drug Development Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=470598"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470598\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=470598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=470598"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=470598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}